Epstein–barr virus strain variation

Current Topics in Microbiology and Immunology

Volumn 390, Issue , 2015, Pages 45-69

  Farrell, Paul J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EBNA3 PROTEIN; EBNAL1 PROTEIN; EPSTEIN BARR VIRUS ANTIGEN 2; LMP1 PROTEIN; LMP2A PROTEIN; UNCLASSIFIED DRUG;

B LYMPHOCYTE; BURKITT LYMPHOMA; CELL TRANSFORMATION; DNA SEQUENCE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS TYPE 1; EPSTEIN BARR VIRUS TYPE 2; GENE SEQUENCE; GENETIC DIFFERENCE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; INCIDENCE; LYMPHOBLASTOID CELL LINE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS STRAIN; WILD TYPE;

EID: 84942903614     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/978-3-319-22822-8_4     Document Type: Chapter

References (167)

1. Adldinger HK, Delius H, Freese UK, Clarke J, Bornkamm GW (1985) A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 141(2):221–234
2. Ai J, Xie Z, Liu C, Huang Z, Xu J (2012) Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children. Virol J 9:13. doi:10.1186/1743-422X-9-13
3. Arrand JR, Rymo L, Walsh JE, Bjorck E, Lindahl T, Griffin BE (1981) Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments. Nucleic Acids Res 9(13):2999–3014
4. Arrand JR, Young LS, Tugwood JD (1989) Two families of sequences in the small RNAencoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. J Virol 63(2):983–986
5. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell P, Barrell B (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310(5974):207–211
6. Banko A, Lazarevic I, Cupic M, Stevanovic G, Boricic I, Jovanovic T (2012) Carboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients. J Med Virol 84(4):632–642. doi:10.1002/jmv.23217
7. Bell MJ, Brennan R, Miles JJ, Moss DJ, Burrows JM, Burrows SR (2008) Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response. J Infect Dis 197(11):1594–1597. doi:10.1086/587848
8. BenAyed-Guerfali D, Ayadi W, Miladi-Abdennadher I, Khabir A, Sellami-Boudawara T, Gargouri A, Mokdad-Gargouri R (2011) Characteristics of Epstein Barr virus variants associated with gastric carcinoma in southern Tunisia. Virol J 8:500. doi:10.1186/1743-422X-8-500
9. Berger C, Rothenberger S, Bachmann E, McQuain C, Nadal D, Knecht H (1999) Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBVassociated reactive and malignant lympho-proliferations. Int J Cancer 81(3):371–375
10. Bhatia K, Raj A, Guitierrez MI, Judde JG, Spangler G, Venkatesh H, Magrath IT (1996) Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt’s lymphomas. Oncogene 13(1):177–181
11. Burrows JM, Bromham L, Woolfit M, Piganeau G, Tellam J, Connolly G, Webb N, Poulsen L, Cooper L, Burrows SR, Moss DJ, Haryana SM, Ng M, Nicholls JM, Khanna R (2004) Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast Asia. J Virol 78(13):7131–7137. doi:10.1128/JVI.78.13.7131-7137.2004
12. Busson P, Edwards RH, Tursz T, Raab-Traub N (1995) Sequence polymorphism in the Epstein- Barr virus latent membrane protein (LMP)-2 gene. J Gen Virol 76(Pt 1):139–145
13. Cancian L, Bosshard R, Lucchesi W, Karstegl CE, Farrell PJ (2011) C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7. PLoS Pathog 7(7):e1002164. doi:10.1371/journal.ppat.1002164
14. Chang KP, Hao SP, Lin SY, Ueng SH, Pai PC, Tseng CK, Hsueh C, Hsieh MS, Yu JS, Tsang NM (2006) The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma. Laryngoscope 116(4):541–546. doi:10.1097/01.mlg.0000201993.53410.40
15. Chen JN, Ding YG, Feng ZY, Li HG, He D, Du H, Wu B, Shao CK (2010) Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China. J Med Virol 82(4):658–667. doi:10.1002/jmv.21731
16. Chen JN, Jiang Y, Li HG, Ding YG, Fan XJ, Xiao L, Han J, Du H, Shao CK (2011) Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma. Virus Res 160(1–2):191–199. doi:10.1016/j.virusres.2011.06.011
17. Chen JN, Zhang NN, Jiang Y, Hui DY, Wen ZJ, Li HG, Ding YG, Du H, Shao CK (2012) Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China. PLoS ONE 7(11):e50084. doi:10.1371/journal.pone.0050084
18. Chen MR, Tsai CH, Wu FF, Kan SH, Yang CS, Chen JY (1999) The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines. J Gen Virol 80(Pt 2):447–455
19. Cheung A, Kieff E (1982) Long internal direct repeat in Epstein-Barr virus DNA. J Virol 44(1):286–294
20. Cheung ST, Leung SF, Lo KW, Chiu KW, Tam JS, Fok TF, Johnson PJ, Lee JC, Huang DP (1998) Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int J Cancer 76(3):399–406
21. Chu PG, Chang KL, Chen WG, Chen YY, Shibata D, Hayashi K, Bacchi C, Bacchi M, Weiss LM (1999) Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations. Am J Pathol 155(3):941–947. doi:10.1016/S0002-9440(10)65193-0
22. Cohen JI, Fauci AS, Varmus H, Nabel GJ (2011) Epstein-Barr virus: an important vaccine target for cancer prevention. Sci Transl Med 3(107):107fs107. doi:10.1126/scitranslmed.3002878
23. Cohen JI, Picchio GR, Mosier DE (1992) Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro. J Virol 66(12):7555–7559
24. Cohen JI, Wang F, Mannick J, Kieff E (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci USA 86(23):9558–9562
25. Coleman CB, Wohlford EM, Smith NA, King CA, Ritchie JA, Baresel PC, Kimura H, Rochford R (2015) Epstein-barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines. J Virol 89(4):2301–2312. doi:10.1128/JVI.03001-14
26. Correa RM, Fellner MD, Alonio LV, Durand K, Teyssie AR, Picconi MA (2004) Epstein-Barr virus (EBV) in healthy carriers: distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene. J Med Virol 73(4):583–588. doi:10.1002/jmv.20129
27. Correa RM, Fellner MD, Durand K, Redini L, Alonio V, Yampolsky C, Colobraro A, Sevlever G, Teyssie A, Benetucci J, Picconi MA (2007) Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients. J Med Virol 79(4):401–407. doi:10.1002/jmv.20782
28. Corvalan A, Ding S, Koriyama C, Carrascal E, Carrasquilla G, Backhouse C, Urzua L, Argandona J, Palma M, Eizuru Y, Akiba S (2006) Association of a distinctivestrain of Epstein-Barr virus with gastric cancer. Int J Cancer 118(7):1736–1742. doi:10.1002/ijc.21530
29. Crawford DH, Macsween KF, Higgins CD, Thomas R, McAulay K, Williams H, Harrison N, Reid S, Conacher M, Douglas J, Swerdlow AJ (2006) A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin Infect Dis 43(3):276–282
30. Dambaugh T, Hennessy K, Chamnankit L, Kieff E (1984) U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 81(23):7632–7636
31. Dambaugh TR, Kieff E (1982) Identification and nucleotide sequences of two similar tandem direct repeats in Epstein-Barr virus DNA. J Virol 44(3):823–833
32. Dardari R, Khyatti M, Cordeiro P, Odda M, ElGueddari B, Hassar M, Menezes J (2006) High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients. Int J Cancer 118(8):1977–1983. doi:10.1002/ijc.21595
33. de Jesus O, Smith PR, Spender L, Karstegl CE, Niller H, Huang D, Farrell PJ (2003) Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J Gen Virol 84:1443–1450
34. Decaussin G, Leclerc V, Ooka T (1995) The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame. J Virol 69(11):7309–7314
35. Depledge DP, Palser AL, Watson SJ, Lai IY, Gray ER, Grant P, Kanda RK, Leproust E, Kellam P, Breuer J (2011) Specific capture and whole-genome sequencing of viruses from clinical samples. PLoS ONE 6(11):e27805. doi:10.1371/journal.pone.0027805
36. Desgranges C, Lenoir G, de-The G, Seigneurin JM, Hilgers J, Dubouch P (1976) In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes. Biomedicine 25(9):349–352
37. Diduk SV, Smirnova KV, Pavlish OA, Gurtsevitch VE (2008) Functionally significant mutations in the Epstein-Barr virus LMP1 gene and their role in activation of cell signaling pathways. Biochemistry Biokhimiia 73(10):1134–1139
38. Do NV, Ingemar E, Phi PT, Jenny A, Chinh TT, Zeng Y, Hu L (2008) A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. Virus Res 132(1–2):15–24. doi:10.1016/j.virusres.2007.10.020
39. Dolan A, Addison C, Gatherer D, Davison AJ, McGeoch DJ (2006) The genome of Epstein-Barr virus type 2 strain AG876. Virology 350(1):164–170
40. Duraiswamy J, Burrows JM, Bharadwaj M, Burrows SR, Cooper L, Pimtanothai N, Khanna R (2003) Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions. J Virol 77(13):7401–7410
41. Edwards RH, Sitki-Green D, Moore DT, Raab-Traub N (2004) Potential selection of LMP1 variants in nasopharyngeal carcinoma. J Virol 78(2):868–881
42. Fafi-Kremer S, Morand P, Germi R, Ballout M, Brion JP, Genoulaz O, Nicod S, Stahl JP, Ruigrok RW, Seigneurin JM (2005) A prospective follow-up of Epstein-Barr virus LMP1 genotypes in saliva and blood during infectious mononucleosis. J Infect Dis 192(12):2108–2111. doi:10.1086/498215
43. Farrell P (1998) Signal transduction from the Epstein-Barr virus LMP-1 transforming protein. Trends Microbiol 6:175–177
44. Fruscalzo A, Marsili G, Busiello V, Bertolini L, Frezza D (2001) DNA sequence heterogeneity within the Epstein-Barr virus family of repeats in the latent origin of replication. Gene 265(1–2):165–173
45. Gan YJ, Razzouk BI, Su T, Sixbey JW (2002) A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin’s disease. Am J Pathol 160(3):781–786. doi:10.1016/S0002-9440(10)64900-0
46. Gantuz M, Lorenzetti MA, Altcheh J, De Matteo E, Moscatelli G, Moroni S, Chabay PA, Preciado MV (2013) LMP1 promoter sequence analysis in Epstein Barr virus pediatric infection reveals preferential circulation of B95. 8 related variants in Argentina. Infection Genet Evol (journal of molecular epidemiology and evolutionary genetics in infectious diseases) 14:275–281. doi:10.1016/j.meegid.2012.12.025
47. Giron LB, Ramos da Silva S, Barbosa AN, Monteiro de Barros Almeida RA, Rosario de Souza L, Elgui de Oliveira D (2013) Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus. J Med Virol 85(12):2110–2118. doi:10.1002/jmv.23722
48. Gorzer I, Niesters HG, Cornelissen JJ, Puchhammer-Stockl E (2006) Characterization of Epstein-Barr virus type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes. Virus Res 118(1–2):105–114. doi:10.1016/j.virusres.2005.11.020
49. Habeshaw G, Yao QY, Bell AI, Morton D, Rickinson AB (1999) Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt’s lymphoma reflect virus strains prevalent in different geographic areas. J Virol 73(2):965–975
50. Hadhri-Guiga B, Khabir AM, Mokdad-Gargouri R, Ghorbel AM, Drira M, Daoud J, Frikha M, Jlidi R, Gargouri A (2006) Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients. Virus Res 115(1):24–30. doi:10.1016/j.virusres.2005.07.002
51. Han J, Chen JN, Zhang ZG, Li HG, Ding YG, Du H, Shao CK (2012) Sequence variations of latent membrane protein 2A in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China. PLoS ONE 7(3):e34276. doi:10.1371/journal.pone.0034276
52. Hatfull G, Bankier AT, Barrell BG, Farrell PJ (1988) Sequence analysis of Raji Epstein-Barr virus DNA. Virology 164(2):334–340
53. Hayashi K, Chen WG, Chen YY, Murakami I, Chen HL, Ohara N, Nose S, Hamaya K, Matsui S, Bacchi MM, Bacchi CE, Chang KL, Weiss LM (1998) Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes. Am J Pathol 152(1):191–198
54. Hicks MR, Balesaria S, Medina-Palazon C, Pandya MJ, Woolfson DN, Sinclair AJ (2001) Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lytic-switch protein BZLF1. J Virol 75(11):5381–5384. doi:10.1128/JVI.75.11.5381-5384.2001
55. Higa M, Kinjo T, Kamiyama K, Iwamasa T, Hamada T, Iyama K (2002) Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan. J Clin Pathol 55(6):414–423
56. Horst D, Burrows SR, Gatherer D, van Wilgenburg B, Bell MJ, Boer IG, Ressing ME, Wiertz EJ (2012) Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variation. J Virol 86(1):572–577. doi:10.1128/JVI.05151-11
57. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, Winberg G (1993) Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 8(6):1575–1583
58. Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G (1991) Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 72(Pt 10):2399–2409
59. Huen DS, Henderson SA, Croom-Carter D, Rowe M (1995) The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10(3):549–560
60. Hutajulu SH, Hoebe EK, Verkuijlen SA, Fachiroh J, Hariwijanto B, Haryana SM, Stevens SJ, Greijer AE, Middeldorp JM (2010) Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma. Infect Agents Cancer 5:16. doi:10.1186/1750-9378-5-16
61. Imajoh M, Hashida Y, Murakami M, Maeda A, Sato T, Fujieda M, Wakiguchi H, Daibata M (2012) Characterization of Epstein-Barr virus (EBV) BZLF1 gene promoter variants and comparison of cellular gene expression profiles in Japanese patients with infectious mononucleosis, chronic active EBV infection, and EBV-associated hemophagocytic lymphohistiocytosis. J Med Virol 84(6):940–946. doi:10.1002/jmv.23299
62. Jen KY, Higuchi M, Cheng J, Li J, Wu LY, Li YF, Lin HL, Chen Z, Gurtsevitch V, Fujii M, Saku T (2005) Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lympho epithelial carcinomas. Virus Genes 30(2):223–235. doi:10.1007/s11262-004-5630-5
63. Jenkins P, Farrell P (1996) Are particular Epstein-Barr virus strains linked to disease? Semin Cancer Biol 7:209–215
64. Ji KM, Li CL, Meng G, Han AD, Wu XL (2008) New BZLF1 sequence variations in EBVassociated undifferentiated nasopharyngeal carcinoma in southern China. Arch Virol 153(10):1949–1953. doi:10.1007/s00705-008-0195-6
65. Jia Y, Wang Y, Chao Y, Jing Y, Sun Z, Luo B (2010) Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas. Virol J 7:341. doi:10.1186/1743-422X-7-341
66. Jin Y, Xie Z, Lu G, Yang S, Shen K (2010) Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children. Virol J 7:92. doi:10.1186/1743-422X-7-92
67. Jing YZ, Wang Y, Jia YP, Luo B (2010) Polymorphisms of Epstein-Barr virus BHRF1 gene, a homologue of bcl-2. Chin J Cancer 29(12):1000–1005
68. Kanai K, Satoh Y, Saiki Y, Ohtani H, Sairenji T (2007) Difference of Epstein-Barr virus isolates from Japanese patients and African Burkitt’s lymphoma cell lines based on the sequence of latent membrane protein 1. Virus Genes 34(1):55–61. doi:10.1007/s11262-006-0010-y
69. Kanda T, Shibata S, Saito S, Murata T, Isomura H, Yoshiyama H, Takada K, Tsurumi T (2011) Unexpected instability of family of repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC systems. PLoS ONE 6(11):e27758. doi:10.1371/journal.pone.0027758
70. Kawaguchi A, Kanai K, Satoh Y, Touge C, Nagata K, Sairenji T, Inoue Y (2009) The evolution of Epstein-Barr virus inferred from the conservation and mutation of the virus glycoprotein gp350/220 gene. Virus Genes 38(2):215–223. doi:10.1007/s11262-008-0323-0
71. Kelly G, Bell A, Rickinson A (2002) Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat Med 8(10):1098–1104
72. Kelly GL, Long HM, Stylianou J, Thomas WA, Leese A, Bell AI, Bornkamm GW, Mautner J, Rickinson AB, Rowe M (2009) An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link. PLoS Pathog 5(3):e1000341. doi:10.1371/journal.ppat.1000341
73. Khanim F, Dawson C, Meseda CA, Dawson J, Mackett M, Young LS (1997) BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates. J Gen Virol 78(Pt 11):2987–2999
74. Khanna R, Moss DJ, Burrows SR (1999) Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation. Immunol Rev 170:49–64
75. Kim SM, Kang SH, Lee WK (2006) Identification of two types of naturally-occurring intertypic recombinants of Epstein-Barr virus. Mol Cells 21(2):302–307
76. Kwok H, Tong AH, Lin CH, Lok S, Farrell PJ, Kwong DL, Chiang AK (2012) Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy. PLoS ONE 7(5):e36939. doi:10.1371/journal.pone.0036939
77. Kwok H, Wu CW, Palser AL, Kellam P, Sham PC, Kwong DL, Chiang AK (2014) Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsies. J Virol 88:10662–10672. doi:10.1128/JVI.01665-14
78. Larcher C, Bernhard D, Schaadt E, Adler B, Ausserlechner MJ, Mitterer M, Huemer HP (2003) Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants. Haematologica 88(12):1324–1335
79. Lay ML, Lucas RM, Toi C, Ratnamohan M, Ponsonby AL, Dwyer DE (2012) Epstein-Barr virus genotypes and strains in central nervous system demyelinating disease and Epstein-Barr virus-related illnesses in Australia. Intervirology 55(5):372–379. doi:10.1159/000334693
80. Lee SP, Thomas WA, Murray RJ, Khanim F, Kaur S, Young LS, Rowe M, Kurilla M, Rickinson AB (1993) HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J Virol 67(12):7428–7435
81. Lei H, Li T, Hung GC, Li B, Tsai S, Lo SC (2013) Identification and characterization of EBV genomes in spontaneously immortalized human peripheral blood B lymphocytes by NGS technology. BMC Genom 14:804. doi:10.1186/1471-2164-14-804
82. Li A, Zhang XS, Jiang JH, Wang HH, Liu XQ, Pan ZG, Zeng YX (2005) Transcriptional expression of RPMS1 in nasopharyngeal carcinoma and its oncogenic potential. Cell Cycle 4(2):304–309
83. Li DJ, Bei JX, Mai SJ, Xu JF, Chen LZ, Zhang RH, Yu XJ, Hong MH, Zeng YX, Kang T (2009) The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma. J Med Virol 81(7):1253–1260. doi:10.1002/jmv.21503
84. Lin HJ, Cherng JM, Hung MS, Sayion Y, Lin JC (2005) Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan. J Biomed Sci 12(6):925–936. doi:10.1007/s11373-005-9017-y
85. Lin JC, Cherng JM, Lin HJ, Tsang CW, Liu YX, Lee SP (2004) Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted ‘epitope-loss variant’. J Gen Virol 85(Pt 7):2023–2034. doi:10.1099/vir.0.19696-0
86. Lin Z, Wang X, Strong MJ, Concha M, Baddoo M, Xu G, Baribault C, Fewell C, Hulme W, Hedges D, Taylor CM, Flemington EK (2013) Whole-genome sequencing of the Akata and Mutu Epstein-Barr virus strains. J Virol 87(2):1172–1182. doi:10.1128/JVI.02517-12
87. Liu P, Fang X, Feng Z, Guo YM, Peng RJ, Liu T, Huang Z, Feng Y, Sun X, Xiong Z, Guo X, Pang SS, Wang B, Lv X, Feng FT, Li DJ, Chen LZ, Feng QS, Huang WL, Zeng MS, Bei JX, Zhang Y, Zeng YX (2011) Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology. J Virol 85(21):11291–11299. doi:10.1128/JVI.00823-11
88. Lorenzetti MA, Gantuz M, Altcheh J, De Matteo E, Chabay PA, Preciado MV (2012) Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms. J Clin Microbiol 50(3):609–618. doi:10.1128/JCM.05778-11
89. Lorenzetti MA, Gantuz M, Altcheh J, De Matteo E, Chabay PA, Preciado MV (2014) Epstein- Barr virus BZLF1 gene polymorphisms: malignancy related or geographically distributed variants? Clin Microbiol Infect (the official publication of the European Society of Clinical Microbiology and Infectious Diseases) 20:O861–O869. doi:10.1111/1469-0691.12631
90. Lucchesi W, Brady G, Dittrich-Breiholz O, Kracht M, Russ R, Farrell PJ (2008) Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2. J Virol 82(15):7456–7466
91. Luo B, Liu M, Chao Y, Wang Y, Jing Y, Sun Z (2012) Characterization of Epstein-Barr virus gp350/220 gene variants in virus isolates from gastric carcinoma and nasopharyngeal carcinoma. Arch Virol 157(2):207–216. doi:10.1007/s00705-011-1148-z
92. Luo B, Tang X, Jia Y, Wang Y, Chao Y, Zhao C (2011) Sequence variation of Epstein-Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in northern China. Microbes Infect (Institut Pasteur) 13(8–9):776–782. doi:10.1016/j.micinf.2011.04.002
93. Mai SJ, Xie D, Huang YF, Wang FW, Liao YJ, Deng HX, Liu WJ, Hua WF, Zeng YX (2010) The enhanced transcriptional activity of the V-val subtype of Epstein-Barr virus nuclear antigen 1 in epithelial cell lines. Oncol Rep 23(5):1417–1424
94. Mainou BA, Raab-Traub N (2006) LMP1 strain variants: biological and molecular properties. J Virol 80(13):6458–6468. doi:10.1128/JVI.00135-06
95. Martini M, Capello D, Serraino D, Navarra A, Pierconti F, Cenci T, Gaidano G, Larocca LM (2007) Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. J Infect 54(3):298–306. doi:10.1016/j.jinf.2006.04.015
96. McGeoch DJ, Gatherer D (2007) Lineage structures in the genome sequences of three Epstein-Barr virus strains. Virology 359(1):1–5. doi:10.1016/j.virol.2006.10.009
97. Midgley RS, Bell AI, McGeoch DJ, Rickinson AB (2003a) Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes. J Virol 77(21):11517–11530
98. Midgley RS, Bell AI, Yao QY, Croom-Carter D, Hislop AD, Whitney BM, Chan AT, Johnson PJ, Rickinson AB (2003b) HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences. J Virol 77(21):11507–11516
99. Midgley RS, Blake NW, Yao QY, Croom-Carter D, Cheung ST, Leung SF, Chan AT, Johnson PJ, Huang D, Rickinson AB, Lee SP (2000) Novel intertypic recombinants of Epstein-Barr virus in the Chinese population. J Virol 74(3):1544–1548
100. Miller G, Shope T, Lisco H, Stitt D, Lipman M (1972) Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci USA 69(2):383–387
101. Miller WE, Edwards RH, Walling DM, Raab-Traub N (1994) Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol 75(Pt 10):2729–2740
102. Nagamine M, Kishibe K, Takahara M, Nagato T, Ishii H, Bandoh N, Ogino T, Harabuchi Y (2007) Selected amino acid change encoding Epstein-Barr virus-specific T cell epitope of the LMP2A gene in Japanese nasal NK/T cell lymphoma patients. Intervirology 50(5):319–322. doi:10.1159/000106462
103. Nguyen-Van D, Ernberg I, Phan-Thi Phi P, Tran-Thi C, Hu L (2008) Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1. Virus Genes 37(2):273–281. doi:10.1007/s11262-008-0262-9
104. Nie Y, Sun Y, Wang Y, Liu C, Zhao C, Luo B (2013) Epstein-Barr virus gene polymorphism in different parts of the same nasopharyngeal carcinoma patient. Arch Virol 158(5):1031–1037. doi:10.1007/s00705-012-1578-2
105. Pai PC, Tseng CK, Chuang CC, Wei KC, Hao SP, Hsueh C, Chang KP, Tsang NM (2007) Polymorphism of C-terminal activation region 2 of Epstein-Barr virus latent membrane protein 1 in predicting distant failure and post-metastatic survival in patients with nasopharyngeal carcinoma. Head Neck 29(2):109–119. doi:10.1002/hed.20483
106. Palefsky JM, Berline J, Greenspan D, Greenspan JS (2002) Evidence for trafficking of Epstein- Barr virus strains between hairy leukoplakia and peripheral blood lymphocytes. J Gen Virol 83(Pt 2):317–321
107. Palma I, Sanchez AE, Jimenez-Hernandez E, Alvarez-Rodriguez F, Nava-Frias M, Valencia-Mayoral P, Salinas-Lara C, Velazquez-Guadarrama N, Portilla-Aguilar J, Pena RY, Ramos-Salazar P, Contreras A, Alfaro A, Espinosa AM, Najera N, Gutierrez G, Mejia-Arangure JM, Arellano-Galindo J (2013) Detection of Epstein-Barr virus and genotyping based on EBNA2 protein in Mexican patients with hodgkin lymphoma: a comparative study in children and adults. Clin Lymphoma Myeloma Leuk 13(3):266–272. doi:10.1016/j.clml.2012.11.010
108. Palser AL, Grayson NE, White RE, Corton C, Correia S, Ba abdullah MM, Watson SJ, Cotten M, Arrand JR, Murray P, Allday MJ, Rickinson AB, Young LS, Farrell PJ, Kellam P (2015) Genome diversity of Epstein-Barr virus from multiple tumour types and normal infection. J Virol 89:5222–5237
109. Parker BD, Bankier A, Satchwell S, Barrell B, Farrell PJ (1990) Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology 179(1):339–346
110. Patton DF, Shirley P, Raab-Traub N, Resnick L, Sixbey JW (1990) Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia. J Virol 64(1):397–400
111. Pavlish OA, Diduk SV, Smirnova KV, Shcherbak LN, Goncharova EV, Shalginskikh NA, Arkhipov VV, Kichigina M, Stepina VN, Belousova NV, Osmanov EA, Iakovleva LS, Gurtsevich VE (2008) Mutations of the Epstein-Barr virus LMP1 gene mutations in Russian patients with lymphoid pathology and healthy individuals. Vopr Virusol 53(1):10–16
112. Qiu J, Smith P, Leahy L, Thorley-Lawson DA (2015) The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo. PLoS Pathog 11(1):e1004561. doi:10.1371/journal.ppat.1004561
113. Raab-Traub N, Dambaugh T, Kieff E (1980) DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell 22(1 Pt 1):257–267
114. Rey J, Xerri L, Bouabdallah R, Keuppens M, Brousset P, Meggetto F (2008) Detection of different clonal EBV strains in Hodgkin lymphoma and nasopharyngeal carcinoma tissues from the same patient. Br J Haematol 142(1):79–81. doi:10.1111/j.1365-2141.2008.07162.x
115. Rickinson AB (2014) Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol 26C:99–115. doi:10.1016/j.semcancer.2014.04.004
116. Rickinson AB, Kieff E (2007) Epstein-Barr virus. In: Knipe D, Howley PM (eds) Fields virology, vol 2, 5th edn. Lippincott-Raven, Philadelphia, pp 2680–2700
117. Rickinson AB, Moss DJ (1997) Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 15:405–431
118. Rickinson AB, Young LS, Rowe M (1987) Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 61(5):1310–1317
119. Rooney C, Taylor N, Countryman J, Jenson H, Kolman J, Miller G (1988) Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency. Proc Natl Acad Sci USA 85(24):9801–9805
120. Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickinson AB (1989) Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J Virol 63(3):1031–1039
121. Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB (1991) Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 173(1):147–158
122. Ryan JL, Jones RJ, Elmore SH, Kenney SC, Miller G, Schroeder JC, Gulley ML (2009) Epstein-Barr virus WZhet DNA can induce lytic replication in epithelial cells in vitro, although WZhet is not detectable in many human tissues in vivo. Intervirology 52(1):8–16. doi:10.1159/000210833
123. Saechan V, Mori A, Mitarnun W, Settheetham-Ishida W, Ishida T (2006) Analysis of LMP1 variants of EBV in southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity. J Clin Virol 36(2):119–125. doi:10.1016/j.jcv.2006.01.018
124. Saechan V, Settheetham-Ishida W, Kimura R, Tiwawech D, Mitarnun W, Ishida T (2010) Epstein-Barr virus strains defined by the latent membrane protein 1 sequence characterize Thai ethnic groups. J Gen Virol 91(Pt 8):2054–2061. doi:10.1099/vir.0.021105-0
125. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E (1990) Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 64(9):4084–4092
126. Schuster V, Ott G, Seidenspinner S, Kreth HW (1996) Common Epstein-Barr virus (EBV) type-1 variant strains in both malignant and benign EBV-associated disorders. Blood 87(4):1579–1585
127. See HS, Yap YY, Yip WK, Seow HF (2008) Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia. World J Surg Oncol 6:18. doi:10.1186/1477-7819-6-18
128. Senyuta N, Yakovleva L, Goncharova E, Scherback L, Diduk S, Smirnova K, Maksimovich D, Gurtsevitch V (2014) Epstein-barr virus latent membrane protein 1 polymorphism in nasopharyngeal carcinoma and other oral cavity tumors in Russia. J Med Virol 86(2):290–300. doi:10.1002/jmv.23729
129. Shibata Y, Hoshino Y, Hara S, Yagasaki H, Kojima S, Nishiyama Y, Morishima T, Kimura H (2006) Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection. J Med Virol 78(6):770–779. doi:10.1002/jmv.20622
130. Sitki-Green D, Covington M, Raab-Traub N (2003) Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J Virol 77(3):1840–1847
131. Sitki-Green D, Edwards RH, Webster-Cyriaque J, Raab-Traub N (2002) Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay. J Virol 76(19):9645–9656
132. Sitki-Green DL, Edwards RH, Covington MM, Raab-Traub N (2004) Biology of Epstein-Barr virus during infectious mononucleosis. J Infect Dis 189(3):483–492. doi:10.1086/380800
133. Snudden DK, Smith PR, Lai D, Ng MH, Griffin BE (1995) Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours. Oncogene 10(8):1545–1552
134. Strockbine LD, Cohen JI, Farrah T, Lyman SD, Wagener F, DuBose RF, Armitage RJ, Spriggs MK (1998) The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J Virol 72(5):4015–4021
135. Sung NS, Edwards RH, Seillier-Moiseiwitsch F, Perkins AG, Zeng Y, Raab-Traub N (1998) Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and nonendemic regions of China. Int J Cancer 76(2):207–215
136. Suspene R, Aynaud MM, Koch S, Pasdeloup D, Labetoulle M, Gaertner B, Vartanian JP, Meyerhans A, Wain-Hobson S (2011) Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo. J Virol 85(15):7594–7602. doi:10.1128/JVI.00290-11
137. Szpara ML, Gatherer D, Ochoa A, Greenbaum B, Dolan A, Bowden RJ, Enquist LW, Legendre M, Davison AJ (2014) Evolution and diversity in human herpes simplex virus genomes. J Virol 88(2):1209–1227. doi:10.1128/JVI.01987-13
138. Tai YC, Kim LH, Peh SC (2004) High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract. Pathol Int 54(3):158–166. doi:10.1111/j.1440-1827.2003.01602.x
139. Tanaka M, Kawaguchi Y, Yokofujita J, Takagi M, Eishi Y, Hirai K (1999) Sequence variations of Epstein-Barr virus LMP2A gene in gastric carcinoma in Japan. Virus Genes 19(2):103–111
140. Tang YL, Lu JH, Cao L, Wu MH, Peng SP, Zhou HD, Huang C, Yang YX, Zhou YH, Chen Q, Li XL, Zhou M, Li GY (2008) Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes. Braz J Med Biol Res (Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica [et al]) 41(2):110–116
141. Taylor GS, Jia H, Harrington K, Lee LW, Turner J, Ladell K, Price DA, Tanday M, Matthews J, Roberts C, Edwards C, McGuigan L, Hartley A, Wilson S, Hui EP, Chan AT, Rickinson AB, Steven NM (2014) A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer. Clin Cancer Res. doi:10.1158/1078-0432.CCR-14-1122-T
142. Tierney RJ, Edwards RH, Sitki-Green D, Croom-Carter D, Roy S, Yao QY, Raab-Traub N, Rickinson AB (2006) Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assays. J Infect Dis 193(2):287–297. doi:10.1086/498913
143. Tierney RJ, Kao KY, Nagra JK, Rickinson AB (2011) Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains. J Virol 85(23):12362–12375. doi:10.1128/JVI.06059-11
144. Tomkinson B, Kieff E (1992) Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection. J Virol 66(2):780–789
145. Tsai MH, Raykova A, Klinke O, Bernhardt K, Gartner K, Leung CS, Geletneky K, Sertel S, Munz C, Feederle R, Delecluse HJ (2013) Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas. Cell Rep 5(2):458–470. doi:10.1016/j.celrep.2013.09.012
146. Tso KK, Yip KY, Mak CK, Chung GT, Lee SD, Cheung ST, To KF, Lo KW (2013) Complete genomic sequence of Epstein-Barr virus in nasopharyngeal carcinoma cell line C666-1. Infect Agents Cancer 8(1):29. doi:10.1186/1750-9378-8-29
147. Tzellos S, Correia PB, Karstegl CE, Cancian L, Cano-Flanagan J, McClellan MJ, West MJ, Farrell PJ (2014) A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2. J Virol 88:8743–8753. doi:10.1128/JVI.01000-14
148. Tzellos S, Farrell PJ (2012) Epstein-Barr virus sequence variation—biology and disease. Pathogens 1:156–174
149. Vaysberg M, Hatton O, Lambert SL, Snow AL, Wong B, Krams SM, Martinez OM (2008) Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos. J Biol Chem 283(52):36573–36585. doi:10.1074/jbc.M802968200
150. Walling DM, Brown AL, Etienne W, Keitel WA, Ling PD (2003) Multiple Epstein-Barr virus infections in healthy individuals. J Virol 77(11):6546–6550
151. Walling DM, Etienne W, Ray AJ, Flaitz CM, Nichols CM (2004) Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia. J Infect Dis 190(2):387–395. doi:10.1086/421708
152. Wang FW, Wu XR, Liu WJ, Liang YJ, Huang YF, Liao YJ, Shao CK, Zong YS, Mai SJ, Xie D (2012a) The nucleotide polymorphisms within the Epstein-Barr virus C and Q promoters from nasopharyngeal carcinoma affect transcriptional activity in vitro. Eur Arch oto-Rhino-Laryngol (official journal of the European Federation of Oto-Rhino-Laryngological Societies) 269(3):931–938. doi:10.1007/s00405-011-1862-x
153. Wang X, Liu X, Jia Y, Chao Y, Xing X, Wang Y, Luo B (2010a) Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates. J Gen Virol 91(Pt 10):2564–2573. doi:10.1099/vir.0.021881-0
154. Wang X, Wang Y, Wu G, Chao Y, Sun Z, Luo B (2012b) Sequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas. Virol J 9:49. doi:10.1186/1743-422X-9-49
155. Wang Y, Kanai K, Satoh Y, Luo B, Sairenji T (2007) Carboxyl-terminal sequence variation of latent membrane protein 1 gene in Epstein-Barr virus-associated gastric carcinomas from Eastern China and Japan. Intervirology 50(3):229–236. doi:10.1159/000100566
156. Wang Y, Wang XF, Sun ZF, Luo B (2012c) Unique variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinoma biopsies. Virus Res 166(1–2):23–30. doi:10.1016/j.virusres.2012.02.022
157. Wang Y, Zhang X, Chao Y, Jia Y, Xing X, Luo B (2010b) New variations of Epstein-Barr virusencoded small RNA genes in nasopharyngeal carcinomas, gastric carcinomas, and healthy donors in northern China. J Med Virol 82(5):829–836. doi:10.1002/jmv.21714
158. White RE, Ramer PC, Naresh KN, Meixlsperger S, Pinaud L, Rooney C, Savoldo B, Coutinho R, Bodor C, Gribben J, Ibrahim HA, Bower M, Nourse JP, Gandhi MK, Middeldorp J, Cader FZ, Murray P, Munz C, Allday MJ (2012) EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Investig 122(4):1487–1502. doi:10.1172/JCI58092
159. Wrightham MN, Stewart JP, Janjua NJ, Pepper SD, Sample C, Rooney CM, Arrand JR (1995) Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208(2):521–530. doi:10.1006/viro.1995.1183
160. Wu G, Wang Y, Chao Y, Jia Y, Zhao C, Luo B (2012) Characterization of Epstein-Barr virus type 1 nuclear antigen 3C sequence patterns of nasopharyngeal and gastric carcinomas in northern China. Arch Virol 157(5):845–853. doi:10.1007/s00705-012-1241-y
161. Yang Y, Jia Y, Wang Y, Wang X, Sun Z, Luo B (2014) Sequence analysis of EBV immediate-early gene BZLF1 and BRLF1 in lymphomas. J Med Virol 86:1788–1795. doi:10.1002/jmv.23911
162. Yao QY, Tierney RJ, Croom-Carter D, Cooper GM, Ellis CJ, Rowe M, Rickinson AB (1996) Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals. J Virol 70(8):4895–4903
163. Zeng MS, Li DJ, Liu QL, Song LB, Li MZ, Zhang RH, Yu XJ, Wang HM, Ernberg I, Zeng YX (2005) Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J Virol 79(24):15323–15330
164. Zhang XS, Song KH, Mai HQ, Jia WH, Feng BJ, Xia JC, Zhang RH, Huang LX, Yu XJ, Feng QS, Huang P, Chen JJ, Zeng YX (2002) The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China. Cancer Lett 176(1):65–73
165. Zhang XS, Wang HH, Hu LF, Li A, Zhang RH, Mai HQ, Xia JC, Chen LZ, Zeng YX (2004) V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma. Cancer Lett 211(1):11–18. doi:10.1016/j.canlet.2004.01.035
166. Zhao S, Liu WP, Wang XL, Zhang WY, Jiang W, Tang Y, Li GD (2005) Detection of the 30 base pair deletion of Epstein-Barr virus latent membrane protein 1 in extranodal nasal type NK/ T-cell lymphoma and its prognostic significance. Zhonghua bing li xue za zhi Chin J Pathol 34(11):720–723
167. Zuercher E, Butticaz C, Wyniger J, Martinez R, Battegay M, Boffi El Amari E, Dang T, Egger JF, Fehr J, Mueller-Garamvogyi E, Parini A, Schaefer SC, Schoeni-Affolter F, Thurnheer C, Tinguely M, Telenti A, Rothenberger S, Swiss HIVCS (2012) Genetic diversity of EBVencoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Kappab activation. PLoS ONE 7(2):e32168. doi:10.1371/journal.pone.0032168